Hormone receptor positive malignant neoplasm of breast Clinical Trials
Conditions / Hormone receptor positive malignant neoplasm of breast
Delta Trials catalogs 18 clinical trials for Hormone receptor positive malignant neoplasm of breast in its publicly accessible dataset. Within this set, 4 currently recruiting participants and 9 trials have reached completion. This research occurs across 189 participating sites around the world. An additional 5 trials are in other active phases such as not yet recruiting or pending status. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.
Trial Status
18
Total Trials
4
Recruiting
9
Completed
5
Other Active
0
Terminated since 2020
189
Study Locations
Browse by location (189 total)
- New York, United States 3 trialsAll trials in New York, United States
- Nashville, United States 3 trialsAll trials in Nashville, United States
- St. Louis, United States 3 trialsAll trials in St. Louis, United States
- Detroit, United States 3 trialsAll trials in Detroit, United States
- St. Louis, United States 3 trialsAll trials in St. Louis, United States
- Seoul, South Korea 3 trialsAll trials in Seoul, South Korea
- Fuzhou, China 3 trialsAll trials in Fuzhou, China
- Guangzhou, China 2 trialsAll trials in Guangzhou, China
- Nanchang, China 2 trialsAll trials in Nanchang, China
- Melbourne, Australia 2 trialsAll trials in Melbourne, Australia
- Shenyang, China 2 trialsAll trials in Shenyang, China
- Minneapolis, United States 2 trialsAll trials in Minneapolis, United States
- Nagoya, Japan 2 trialsAll trials in Nagoya, Japan
- Denver, United States 2 trialsAll trials in Denver, United States
- Shanghai, China 2 trialsAll trials in Shanghai, China
- Beijing, China 2 trialsAll trials in Beijing, China
- Chicago, United States 2 trialsAll trials in Chicago, United States
- Boston, United States 2 trialsAll trials in Boston, United States
- Kuala Lumpur, Malaysia 1 trialAll trials in Kuala Lumpur, Malaysia
- Seongbukgu, South Korea 1 trialAll trials in Seongbukgu, South Korea